Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alfresa HoldingsALFRY 77 3-Year Share Buyback Ratio is 3.50 as of Mar. 2026, which is 367% above its 10-year median of 0.75. GuruFocus rates ALFRY with a GF Score™ of 77/100 and a GF Value™ of $16.43 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 71 Medical Distribution companies, Alfresa Holdings ranks better than 92.96% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Alfresa Holdings's current 3-Year Share Buyback Ratio was 3.50%.
The historical rank and industry rank for Alfresa Holdings's 3-Year Share Buyback Ratio or its related term are showing as below:
ALFRY'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -7.9 Med: 0.75 Max: 4.1
Current: 3.5
During the past 13 years, Alfresa Holdings's highest 3-Year Share Buyback Ratio was 4.10%. The lowest was -7.90%. And the median was 0.75%.
ALFRY's 3-Year Share Buyback Ratio is ranked better than 92.96% of 71
companies
in the Medical Distribution industry
Industry Median: -0.5
vs ALFRY: 3.50
Alfresa Holdings (OTCPK:ALFRY) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Alfresa Holdings 3-Year Share Buyback Ratio Related Terms
ALFRY vs MCK, COR, CAH: 3-Year Share Buyback Ratio Comparison
For the Medical Distribution subindustry, Alfresa Holdings's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alfresa Holdings 3-Year Share Buyback Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Alfresa Holdings's 3-Year Share Buyback Ratio falls into.
Alfresa Holdings 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 3.50 mean?
Alfresa Holdings (ALFRY) has a 3-Year Share Buyback Ratio of 3.50 as of Mar. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Alfresa Holdings and its competitors. This is 367% above median its historical median of 0.75. According to the industry distribution chart, Alfresa Holdings ranks #5 out of 71 companies in the Medical Distribution industry, placing it in the top 7%.
Is Alfresa Holdings' 3-Year Share Buyback Ratio too high?
Alfresa Holdings' current 3-Year Share Buyback Ratio of 3.50 is 367% above median its 10-year median of 0.75. Based on the distribution chart, Alfresa Holdings ranks #5 out of 71 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Alfresa Holdings has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alfresa Holdings' 3-Year Share Buyback Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Alfresa Holdings ranks #5 out of 71 companies for 3-Year Share Buyback Ratio. This places Alfresa Holdings in the top 7% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Medical Distribution company?
A good 3-Year Share Buyback Ratio depends on the Medical Distribution industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Alfresa Holdings and its competitors. Alfresa Holdings's current 3-Year Share Buyback Ratio is 3.50, which is 367% above median its own 10-year median of 0.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alfresa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alfresa Holdings (ALFRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.43, compared to a current price of $13.55 — trading 17.5% below its estimated fair value. The current 3-Year Share Buyback Ratio is 3.50, which is 367% above median its 10-year median of 0.75. Alfresa Holdings' overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Alfresa Holdings (ALFRY), the current 3-Year Share Buyback Ratio is 3.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alfresa Holdings (ALFRY) Overvalued in 2026?
Based on GuruFocus' analysis, Alfresa Holdings stock appears to be undervalued.
The current stock price of $13.55 is trading 17.5% below its estimated GF Value™ of $16.43.
GuruFocus considers Alfresa Holdings to be Modestly Undervalued.
Key valuation signals for ALFRY:
3-Year Share Buyback Ratio: 3.50 (367% above median its 10-year median of 0.75)
GF Value™: $16.43 vs. price of $13.55 (17.5% below fair value)
No single metric tells the full story. See the ALFRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
77GF Score
Get the complete analysis for ALFRY
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALFRY has been successfully added to your 
